Avastin Alternatives Compared
| Avastin | Elahere | Carboplatin |
|
|---|
| Avastin (bevacizumab) | Elahere (mirvetuximab soravtansine) | Carboplatin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Fallopian Tube Cancer, Cervical Cancer, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Renal Cell... View more |
Prescription only
Prescribed for Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer. Elahere may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Ovarian Cancer, Cancer, Cervical Cancer. carboplatin may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||||||||||
| More about Avastin (bevacizumab) | More about Elahere (mirvetuximab soravtansine) | More about Carboplatin | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Avastin has an average rating of 7.7 out of 10 from a total of 27 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 13% reported a negative effect. |
Be the first to share your experience with this drug. |
Carboplatin has an average rating of 6.3 out of 10 from a total of 4 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: Avastin side effects in more detail. |
See also: Elahere side effects in more detail. |
Commonly reported side effects include:
See also: carboplatin side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Avastin prices |
View all Elahere prices |
View all carboplatin prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other bevacizumab brands include: Alymsys, Mvasi, Vegzelma, Zirabev |
N/A |
Carboplatin Novaplus | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
480 hours |
115.2 hours |
120 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 29 drugs are known to interact with Avastin:
|
A total of 114 drugs are known to interact with Elahere:
|
A total of 320 drugs are known to interact with carboplatin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
February 26, 2004 |
November 14, 2022 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.